SBI Holdings (FRA:ZOF) Short Ratio


FRA:ZOF SBI Holdings Inc FRA:ZOF
80 GF Score
Price €14.69
GF Value €13.53
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is SBI Holdings Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:ZOF
80GF Score
SBI Holdings Inc FRA:ZOF
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SBI Holdings (FRA:ZOF) Overvalued in 2026?

Based on GuruFocus' analysis, SBI Holdings stock appears to be overvalued. The current stock price of €14.69 is trading 8.6% above its estimated GF Value™ of €13.53. GuruFocus considers SBI Holdings to be Fairly Valued.

Key valuation signals for FRA:ZOF:

  • Short Ratio:
  • GF Value™: €13.53 vs. price of €14.69 (8.6% above fair value)
  • GF Score™: 80/100 with 7 warning signs

No single metric tells the full story. See the FRA:ZOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SBI Holdings Business Description

Address 1-6-1 Roppongi, Minato-ku, Tokyo, JPN, 106-6019
SBI Holdings Inc is a financial conglomerate that offers a variety of services in securities, banking, and insurance. The company operates through five segments. The Asset Management segment provides investment management, advice, and financial product information. The Crypto Asset segment offers crypto exchange and trading services. The Financial Services segment covers securities, banking, and insurance activities in Japan and abroad. The Investment segment invests in IT, fintech, blockchain, finance, and biotech ventures. The Next Generation Business develops and sells pharmaceuticals, health foods, and cosmetics, conducts R&D in cancer and immunology, offers digital medical solutions, and engages in medical finance. It generates majority of its revenue from Financial services segment.
80GF Score

Get the complete analysis for FRA:ZOF

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.69
Price
€13.53
GF Value